Citizens M&A Advisory served as the exclusive M&A advisor to Bionix Development Corporation on its recapitalization by Argosy Private Equity.
Bionix, headquartered in Toledo, OH, is a developer of healthcare products for single-use ear, nasal and wound care applications, among others.
“We are greatly appreciative of the Citizens M&A Advisory team’s guidance throughout this recapitalization process, which has provided us with an ideal partner in Argosy for accelerating growth and maintaining Bionix’s proud legacy and culture in Toledo,” Jim Huttner, M.D., Ph.D., co-founder of Bionox, said.
“Bionix is an exceptional medical device company,” Andrew Male, managing director in Citizens’ healthcare M&A practice, said. “We are excited for our clients to be able to accelerate the company’s growth initiatives through this partnership with Argosy and further build upon the founders’ 30-year legacy of developing innovative, premium healthcare products.”
Argosy Private Equity, founded in 1990, provides capital and operating and financial expertise to lower middle market companies across a range of industries.
Citizens M&A Advisory specializes in middle market mergers and acquisitions as well as later-stage financing transactions.
